NCT06025838Completed
Positive Feedback vs. No-Feedback Games for Behavioral Change
Source: ClinicalTrials.gov · Last updated 14 Aug 2025
Brief summary (registry, in English)
We aim to investigate here whether we can develop a reinforcement learning game which provides game-based feedback to encourage positive actions (behaviors) both inside and outside of the game. Does providing positive reward when participants make decisions which are associated with value-based actions (like those in BA) result in different game decisions? We propose that it will increase positive actions in the game. And, secondly, how does it affect short-term behavior (in one week)? We propose that it will increase pro-health activities and may reduce depressive symptoms.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 171 (actual)
- First submitted
- 30 Aug 2023
- Start date
- 13 Feb 2024
- Primary completion date
- 2 Mar 2024
- Lead sponsor
- Bard College
- Diseases
- Depression
- NCT number
- NCT06025838
What you commit to
- Study type: Interventional
- Participants enrolled: 171
- From 13 Feb 2024 to the primary completion date, 2 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None
Who the study is looking for
- 18-34 years old
- Fluent in English
- Based in the United States
Age in the registry: 18 years to 34 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Online research conducted through Bard College Coordinator of this site? Confirm its status | Annandale-on-Hudson | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.